List of Excipients in API ciclopirox olamine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ciclopirox olamine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Medimetriks Pharmaceuticals Inc | LOPROX | ciclopirox olamine | 43538-540 | BENZYL ALCOHOL | |
| Medimetriks Pharmaceuticals Inc | LOPROX | ciclopirox olamine | 43538-540 | CETYL ALCOHOL | |
| Medimetriks Pharmaceuticals Inc | LOPROX | ciclopirox olamine | 43538-540 | LACTIC ACID | |
| Medimetriks Pharmaceuticals Inc | LOPROX | ciclopirox olamine | 43538-540 | LIGHT MINERAL OIL | |
| Medimetriks Pharmaceuticals Inc | LOPROX | ciclopirox olamine | 43538-540 | MYRISTYL ALCOHOL | |
| Medimetriks Pharmaceuticals Inc | LOPROX | ciclopirox olamine | 43538-540 | OCTYLDODECANOL | |
| Medimetriks Pharmaceuticals Inc | LOPROX | ciclopirox olamine | 43538-540 | POLYSORBATE 60 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ciclopirox olamine
Detailed excipient profiles for ciclopirox olamine
Excipient focus: BENZYL ALCOHOL
ciclopirox olamine drug variants containing BENZYL ALCOHOL
ciclopirox olamine drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
ciclopirox olamine drug variants containing CETYL ALCOHOL
ciclopirox olamine drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COCAMIDE
ciclopirox olamine drug variants containing COCAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Leading Pharma LLC | ciclopirox olamine | 69315-309 |
| >Company | >Ingredient | >NDC |
ciclopirox olamine drug variants not containing COCAMIDE
Excipient focus: COCO DIETHANOLAMIDE
ciclopirox olamine drug variants containing COCO DIETHANOLAMIDE
ciclopirox olamine drug variants not containing COCO DIETHANOLAMIDE
Excipient focus: LACTIC ACID
ciclopirox olamine drug variants containing LACTIC ACID
ciclopirox olamine drug variants not containing LACTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
ciclopirox olamine drug variants containing LIGHT MINERAL OIL
ciclopirox olamine drug variants not containing LIGHT MINERAL OIL
Excipient focus: MINERAL OIL
ciclopirox olamine drug variants containing MINERAL OIL
ciclopirox olamine drug variants not containing MINERAL OIL
Excipient focus: MYRISTYL ALCOHOL
ciclopirox olamine drug variants containing MYRISTYL ALCOHOL
ciclopirox olamine drug variants not containing MYRISTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: OCTYLDODECANOL
ciclopirox olamine drug variants containing OCTYLDODECANOL
ciclopirox olamine drug variants not containing OCTYLDODECANOL
| Company | Ingredient | NDC |
|---|---|---|
| Leading Pharma LLC | ciclopirox olamine | 69315-309 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 60
ciclopirox olamine drug variants containing POLYSORBATE 60
ciclopirox olamine drug variants not containing POLYSORBATE 60
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOSTEARATE
ciclopirox olamine drug variants containing SORBITAN MONOSTEARATE
ciclopirox olamine drug variants not containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
ciclopirox olamine drug variants containing STEARYL ALCOHOL
ciclopirox olamine drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
ciclopirox olamine drug variants containing WATER
ciclopirox olamine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Leading Pharma LLC | ciclopirox olamine | 69315-309 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
